RESTORING ACTIVE MEMORY (RAM)
The goal of RAM is to develop a fully implantable device that can electrically stimulate the brain to improve memory function. The program’s immediate focus is to deliver new treatments for those who have experienced a traumatic brain injury, such as veterans returning from combat. In the long term, such therapies could help patients with a broad range of ailments, from Alzheimer’s to dementia. RAM is part of a broader portfolio of programs within DARPA that support President Obama’s BRAIN initiative.
As part of the RAM project, the University of Pennsylvania (including the Computational Memory Lab, the School of Arts and Sciences and the Perelman School of Medicine) is partnering with the following hospitals, institutes and universities:
- Columbia University
- Dartmouth College
- Emory University
- Thomas Jefferson University
- Mayo Clinic
- National Institutes of Health
- University of Texas Southwestern
- Medtronic, Inc.
- Lawrence Livermore National Labs
For more information, please visit the DARPA RAM website.
RAM Public Data Release
Data from 251 subjects collected during Phase I and Phase II of the RAM project are available for download. The following data are included:
- Electrocorticographic (ECoG) recordings
- Demographic information (age, gender, race/ethnicity, handedness)
- Individual electrode contact atlas location and coordinates for localization
- Freesurfer files: cortical surface rendering
- Seizure onset zone, interictal spiking, and bad lead information
- Experiment design documents
- Session notes, behavioral event data, and iEEG recording data (split by channel) for the following RAM experiments:
- FR1/2: Verbal Free Recall
- CatFR1/2: Categorized Verbal Free Recall
- PAL1/2: Verbal Paired Associates Learning
- YC1/2: Yellow Cab Spatial Navigation
- TH1: Treasure Hunt Spatial Navigation
NOTE: Informed consent has been obtained from each subject to share their data, and personally identifiable information has been removed to protect subject confidentiality.
See our press release for Phase I here for additional information.